SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GLAXO (GLX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Zoltan! who wrote (208)3/5/1999 2:07:00 AM
From: Mike McFarland   of 222
 
Thread: There is an article in the WSJ 3/4/99
titled "Big Drug Firms Discuss Linking Up to Persue
Disease-Causing Genes...They Fear Biotechs
Will Gain Patents and Monopolies On Crucial
Information...Goal of 'Personalized Medicine'.

In the article Allen D. Roses, vice president and
worldwide director of genetics research at Glaxo
is quoted. "If each of us produced our own map..."
(SNP map) "it would take much longer to create and
would be very unlikely that the companies would
accept one another's map as being valid".

The article goes on to site how in only five months
Roses' team at Glaxo found the location of APOe--
the gene associated with Alzheimer's. Also mentioned
is the Glaxo Atlas SNP map project.

Anyway, would like to hear from the thread why
Glaxo feels so threatened by biotech, seems me
they've done fine on their own, and this whole
thing about heading off biotech is a real red
herring. "The consortium would file intellectual-
property claims on teh public snips so the biotech
firms couldn't patent them and sell them back to
the corporations."

I just find it hard to beleive that big pharma
has ever felt threatened...they've been using
small cap biotech as their whores all along, and
they can use their inflated stock to buy what
biotech they need, rather than kill competition.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News